Literature DB >> 17476207

Reversibility of hepatic fibrosis and cirrhosis--is it all hype?

Scott L Friedman1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17476207     DOI： 10.1038/ncpgasthep0813

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN： 1743-4378


× No keyword cloud information.
  12 in total

Review 1.  Fuzheng huayu capsule in the treatment of liver fibrosis: clinical evidence and mechanism of action.

Authors:  Ping Liu
Journal:  Chin J Integr Med       Date:  2012-03-21       Impact factor: 1.978

2.  Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells.

Authors:  Sheng Cao; Usman Yaqoob; Amitava Das; Uday Shergill; Kumaravelu Jagavelu; Robert C Huebert; Chittaranjan Routray; Soha Abdelmoneim; Meher Vasdev; Edward Leof; Michael Charlton; Ryan J Watts; Debabrata Mukhopadhyay; Vijay H Shah
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

Review 3.  Evolving challenges in hepatic fibrosis.

Authors:  Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-29       Impact factor: 46.802

Review 4.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

Review 5.  Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?

Authors:  Youngmin A Lee; Scott L Friedman
Journal:  Antiviral Res       Date:  2014-04-12       Impact factor: 5.970

6.  Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray.

Authors:  Waqar Ahmad; Bushra Ijaz; Sajida Hassan
Journal:  J Transl Med       Date:  2012-03-07       Impact factor: 5.531

7.  Effect of Fuzheng Huayu formula and its actions against liver fibrosis.

Authors:  Chenghai Liu; Yiyang Hu; Lieming Xu; Cheng Liu; Ping Liu
Journal:  Chin Med       Date:  2009-06-29       Impact factor: 5.455

8.  Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats.

Authors:  Hong Ling; Eric Roux; Donna Hempel; Jingzang Tao; Mandy Smith; Scott Lonning; Anna Zuk; Cynthia Arbeeny; Steve Ledbetter
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

9.  Coinheritance of hereditary spherocytosis and reversibility of cirrhosis in a young female patient with hereditary hemochromatosis.

Authors:  A Höblinger; C Erdmann; C P Strassburg; T Sauerbruch; F Lammert
Journal:  Eur J Med Res       Date:  2009-04-16       Impact factor: 2.175

10.  Chinese medicines as a resource for liver fibrosis treatment.

Authors:  Yibin Feng; Kwok-Fan Cheung; Ning Wang; Ping Liu; Tadashi Nagamatsu; Yao Tong
Journal:  Chin Med       Date:  2009-08-20       Impact factor: 5.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.